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Research
Endocrine-disrupting chemicals (EDCs) are 
hormone-like agents present in the environ-
ment that may alter the endocrine system of 
wildlife and humans. In particular, xenoestro-
gens have been hypothesized to be involved in 
develop  mental, reproductive, and malignant 
diseases by mimicking the natural hormone 
17β-estradiol (E2) and interfering with endog-
enous endocrine regulation at specific periods, 
such as during fetal growth. Several organo-
chloride pesticides—polychlorinated biphenyls 
(PCBs), phthalates, and bisphenol A (BPA)—
used in the chemical industry have been con-
sidered as estrogenic EDCs. However, all 
of these EDCs have a very weak affinity for 
binding through the classical nuclear estro-
gen receptors (ERs), 1,000–2,000 times lower 
than that of E2 (Bonefeld-Jorgensen et al. 
2001; Crain et al. 1998; Massaad and Barouki 
1999). Studies of the nuclear transcriptional 
regulatory activities of nonphysiologic estro-
gens have mostly been unable to explain the 
actions of these chemicals in mediating endo-
crine disruption in animals and humans at 
the low pico  molar or nano  molar concentra-
tions widespread in the environment (Calafat 
et al. 2005; Vandenberg et al. 2007). In the 
last few years, EDCs have been reported to 
act through hormone-independent mecha-
nisms (Welshons et al. 2006) or through a 
non  genomic activation of membrane-initiated 
signaling pathways via membrane forms of 
ERs (Alonso-Magdalena et al. 2005; Bulayeva 
and Watson 2004; Nadal et al. 2000; Noguchi 
et al. 2002). Indeed, there is now convinc-
ing evidence that estrogens, in addition to 
the classical regulation of estrogen-responsive 
genes via nuclear ERs, are able to trigger rapid 
membrane activation of a variety of second-
messenger–mediated signal transduction 
pathways (Kelly and Levin 2001; Vasudevan 
and Pfaff 2007), with possible implications 
for cell proliferation, apoptosis, or survival 
(Levin 2002). However, the nature of these 
membrane ER(s), their relation to the classi-
cal ERs, and the precise signaling pathways 
that are activated remain to be elucidated 
(Manavathi and Kumar 2006; Vasudevan and 
Pfaff 2007). Moreover, fetal exposure to xeno-
estrogens is believed to be involved in male 
reproductive and developmental patho  genesis. 
Diethylestylbestrol (DES), a potent synthetic 
estrogen used as an anti  abortive drug in the 
1970s, has a well-known deleterious effect in 
adults exposed in utero (Newbold et al. 2006). 
DES can produce different developmental 
or carcinogenic effects in rodents (Newbold 
2004) when given during specific develop-
mental windows, including fetal or peri  natal 
periods, such as cryptorchidism or breast, 
prostate, or endometrial cancers. However, 
although indirect epidemiologic data show a 
constant increase of testicular cancer in young 
men (Huyghe et al. 2007) and an increased 
relative risk via professional exposure to per-
sistent organic pollutants, no experimental 
model has validated the possible carcinogenic 
role of exposure to xenoestrogens in develop-
ing a testicular germ cell cancer (Rajpert-De 
Meyts 2006).
BPA, initially produced like DES as 
a synthetic estrogen (Dodds and Lawson 
1936), has been rapidly and widely used as 
a cross-linking chemical in the manufacture 
of polycarbonate plastic and epoxy resins. 
Because of incomplete polymerization and 
degradation of the polymers by exposure to 
higher than usual temperatures, BPA leaches 
out from food and beverage containers (Biles 
et al. 1997; Krishnan et al. 1993; Le et al. 
2008), as well as from dental sealants. BPA is 
found in the serum, milk, saliva, and urine of 
humans at nanomolar concentrations (Calafat 
et al. 2005; Olea et al. 1996; Sun et al. 2004; 
Vandenberg et al. 2007). Remarkably, BPA 
has been measured in amniotic fluid at con-
centrations 5-fold higher than those measured 
in maternal plasma (Ikezuki et al. 2002). Fetal 
and peri  natal exposures to BPA in rodents 
have been shown to affect the brain, mam-
mary gland, and reproductive tract, including 
hormone-dependent cancer (Durando et al. 
2007; Ho et al. 2006; Maffini et al. 2006; 
Markey et al. 2001; Munoz-de-Toro et al. 
2005). Although BPA induces an estrogenic 
effect through classi  cal nuclear ERs at high 
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Ba c k g r o u n d: Fetal exposure to environmental estrogens may contribute to hypofertility and/or to 
testicular germ cell cancer. However, many of these xenoestrogens have only a weak affinity for the 
classical estrogen receptors (ERs,) which is 1,000-fold less potent than the affinity of 17β-estradiol 
(E2). Thus, several mechanisms have been suggested to explain how they could affect male germ cell 
proliferation at low environmental relevant concentrations. 
oBjectives: In this study we aimed to explore the possible promoting effect of bisphenol A (BPA) 
on human testicular seminoma cells. BPA is a well-recognized estrogenic endocrine disruptor used 
as a monomer to manufacture poly  carbonate plastic and released from resin-lined food or beverage 
cans or from dental sealants. 
Me t h o d s  a n d r e s u l t s. BPA at very low concentrations (10–9 to 10–12 M) similar to those found 
in human fluids stimulated JKT-1 cell proliferation in vitro. BPA activated both cAMP-dependent 
protein kinase and cGMP-dependent protein kinase pathways and triggered a rapid (15 min) phos-
phorylation of the transcription factor cAMP response-element–binding protein (CREB) and the 
cell cycle regulator retinoblastoma protein (Rb). This non  genomic activation did not involve classi-
cal ERs because it could not be reversed by ICI 182780 (an ER antagonist) or reproduced either by 
E2 or by diethylstilbestrol (a potent synthetic estrogen), which instead triggered a suppressive effect. 
This activation was reproduced only by E2 coupled to bovine serum albumin (BSA), which is unable 
to enter the cell. As with E2-BSA, BPA promoted JKT-1 cell proliferation through a G-protein–
coupled nonclassical membrane ER (GPCR) involving a Gαs and a Gαi/Gαq subunit, as shown by 
the reversible effect observed by the corresponding inhibitors NF449 and pertussis toxin.
co n c l u s i o n: This GPCR-mediated nongenomic action represents—in addition to the classical 
ER-mediated effect—a new basis for evaluating xenoestrogens such as BPA that, at low doses and 
with a high affinity for this GPCR, could interfere with the developmental programming of fetal 
germ cell proliferation and/or differentiation when they cross the placenta. 
key w o r d s : bisphenol A, ER, estrogen receptor, GPCR, PKA, PKG, testicular germ cell cancer. 
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concentrations and with a reduced affinity 
relative to E2 (Gaido et al. 1997; Krishnan 
et al. 1993; Perez et al. 1998), it also is able 
to trigger a non  genomic effect in pancreatic 
islet, endothelial, and hypophysial cells and in 
breast cancer cells by initiating rapid responses 
at low concentrations (Alonso-Magdalena 
et al. 2005; Bulayeva and Watson 2004; 
Nadal et al. 2000; Noguchi et al. 2002).
We recently reported that E2 coupled 
to bovine serum albumin (E2-BSA) stimu-
lated the proliferation of human seminoma 
cells (JKT-1) in vitro through a G-protein–
coupled nonclassical membrane ER (GPCR) 
(Bouskine et al. 2008). In the present study, 
we investigated the hypothesis that BPA could 
stimulate seminoma cell proliferation through 
such a non  genomic action. We observed a 
promoting effect of BPA on seminoma cells 
through a rapid activation of cAMP-depen-
dent protein kinase (PKA) and cGMP-depen-
dent protein kinase (PKG) signaling pathways 
via a GPCR, illustrating that xeno  estrogens, 
suspected to act as deleterious factors in breast 
and prostate cancers, could also act in this 
non  genomic pathway as possible promoting 
agents in testicular germ cell cancer.
Materials and Methods
Cell culture and cell proliferation assay. 
JKT-1, a human testicular pure seminoma cell 
line developed from the testis of a 40-year-old 
man (Kinugawa et al. 1998), expresses pla-
cental alkaline phosphatase (PLAP), a classical 
seminoma marker (Roger et al. 2004) and 
more recently described markers (Santagata 
et al. 2007). Specific embryonic stem cell 
markers for the JKT-1 cell line have been 
described previously (Bouskine et al. 2008). 
JKT-1 cells were maintained in Dulbecco’s 
modified Eagle medium (DMEM; Gibco 
BRL, Cergy Pontoise, France) supplemented 
with penicillin/streptomycin (1%), sodium 
pyruvate (2%), and 10% fetal bovine serum 
(FBS) in a humidified 5% CO2 atmosphere 
at 37°C. Cells were seeded in six-well plates 
(0.6 × 106 cells/well). After 48 hr, the cells 
were washed and estrogen-starved overnight 
in phenol red–free DMEM (Sigma, Lyon, 
France) supplemented with 1% charcoal-
stripped FBS. We then added E2 (Sigma), 
freshly prepared E2-BSA (Sigma) devoid of 
free E2 removed by filtration (Bouskine et al. 
2008), ICI 182780 (ICI; Falsodex; Astra-
Zeneca, Birmingham, UK), BPA, DES, 
dichloro  diphenyl  trichloro  ethane (DDT), 
DMSO (Sigma), or ethanol (as vehicle con-
trol) at different concentrations (pico  molar 
to micro  molar) according to previous studies 
(Bouskine et al. 2008; Roger et al. 2004) and 
at environmentally relevant BPA concentra-
tions (Vandenberg et al. 2007) and incubated 
them for 24 hr. 
We harvested cells using trypsin and 
counted them using Vi-CELL software 
(Beckman Coulter, Margency, France). Results 
are expressed as the percent of variation com-
pared with control.
Western blot analysis. We grew JKT-1 cells 
in 10-cm dishes at a density of 4.9 × 106 cells 
per dish. After 48 hr, the cells were washed 
with phosphate-buffered saline (PBS) and 
incubated overnight in phenol red–free 
DMEM/0.1% BSA; cells were then exposed 
to ligands for different time periods. We pur-
chased forskolin from Sigma and PD 98059 
(PD), H89, KT5823, NF449, and pertussis 
toxin (PTX) from VWR Calbiochem (San 
Diego, CA, USA). After washing cells with 
PBS, we lysed cell pellets in ice-cold lysis Brij 
buffer/NP-40 [50 mM Tris-HCl (pH 7.5), 
1% NP-40, 1% Brij 96 (Fluka, St. Quentin 
Fallavier, France), 1 mM Na3VO4, 10 mM 
β-glycerophosphate, 10 mM NaF, 2 mM 
EDTA, and protease inhibitors (Complete; 
Roche Diagnostics, Meylan, France)]. Lysates 
were sonicated 7 sec on ice twice and then 
centrifuged for 15 min at 14,000 rpm. 
Equal amounts of whole protein extract were 
resolved on a 9% SDS-polyacrylamide gel. 
Proteins were transferred to a polyvinyl difluo-
ride Immobilon-P membrane (Millipore, Saint 
Quentin en Yvelines, France) and probed with 
the antibodies against phosphorylated cAMP 
response-element–binding protein (phospho-
CREB; Cell Signaling, Boston, MA, USA) and 
phosphorylated retinoblastoma protein (phos-
pho-Rb; BD Pharmingen, Le Pont de Claix, 
France). After the blots were stripped, we veri-
fied equal loading of proteins by re  probing 
the same blots with anti-actin antibody (Cell 
Signaling). 
Statistical analysis. Results of cell count 
or densitometric analysis are expressed as per-
centages of variation compared with control. 
We used a nonparametric Mann–Whitney 
test for statistical analysis.
Results
Low doses of BPA stimulate JKT-1 cell pro-
liferation. BPA stimulated JKT-1 cell prolif-
eration at very low doses. The dose–response 
curve had an inversed U-shape, with a weak 
stimulation at 10–6 M that was still present 
at 10–12 M, and a maximum effect around 
10–7/10–9 M (Figure 1A). This stimulation 
was reproduced by E2-BSA, an imperme-
able E2 conjugate (Figure 1B), but not by E2, 
which triggered a significant decrease of cell 
proliferation at a physiologic intra  testicular 
concentration of 10–9 M (Figure 1B), in 
agreement with our previous study (Roger 
et al. 2005).
DDT, an organochloride pesticide with 
anti  androgenic activity, had no effect on 
JKT-1 cell proliferation (Figure 1B). DES, a 
potent synthetic estrogen, acted as a suppres-
sor in a dose-dependent manner, as did E2 
(Figure 2). When BPA was combined with 
either E2 or DES to verify synergic or antago-
nist effect, BPA neutralized the suppressive 
effect of E2 (Figure 2) and completely pre-
vented the DES suppressive effect at the dose 
Figure 1. Stimulation of JKT-1 cell proliferation by 24-hr exposure to (A) various doses of BPA or 
(B) E2 (10–9 M), E2-BSA (10–9 M), or DDT (10–9 M). Values shown are the percent change in cell number 
compared with control (steroid-free medium containing DMSO for BPA or medium containing ethanol for 
estrogens) given as the mean ± SE of three independent experiments. 
*p < 0.05. 
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Figure 2. Effects of 24-hr exposure to E2, E2-BSA, or 
DES alone (each at 10–9 M) or combined with BPA 
(10–9 M) on cell proliferation in JKT-1 cells. Values 
shown are percent change in cell number compared 
with control (steroid-free medium containing DMSO 
for bisphenol A or medium containing ethanol for 
estrogens and DDT) given as the mean ± SE of three 
independent experiments. 
*p < 0.05.
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tested (10–9 M). However, E2-BSA plus BPA 
induced the same effect of each alone, indicat-
ing a lack of synergic or antagonistic effect and 
likely a similarity in the activated pathways 
(Figure 2).
BPA activates PKA and CREB in 
JKT-1 cells. Activation of PKA was neces-
sary for BPA to promote JKT-1 cell prolifera-
tion because H89, a specific PKA inhibitor, 
totally prevented an increase in cell prolif-
eration (Figure 3A). Extracellular stimuli elicit 
changes in gene expression in target cells by 
activating intra  cellular protein kinase cas-
cades that phosphorylate transcription factors 
within the nucleus. CREB is one of these fac-
tors that activates gene transcription after the 
phosphorylation of serine 133 induced by 
a variety of protein kinases, including PKA 
and extracellular-signal-regulated kinase 1/2 
(ERK1/2) (Shaywitz and Greenberg 1999). 
Using an anti–phospho-CREB antibody that 
recognizes phosphorylated serine 133, we 
observed a very rapid (5 min), BPA-induced 
activation of CREB in JKT-1 cells, with max-
imum activation at 30 min (Figure 3B). This 
activation was PKA dependent because H89 
completely abolished CREB phosphorylation 
(data not shown).
The cell cycle regulator Rb is phosphorylated 
during BPA-induced promotion of JKT-1 cells. 
Rb is a nuclear factor that partici  pates in the 
regulation of the cell cycle, interfering with 
cyclin action when non  phosphorylated. This 
suppressive effect is prevented through phos-
phorylation of Rb. In JKT-1 cells, BPA induced 
a rapid (4 hr) and intensive phosphorylation of 
Rb (Figure 4), leading to Rb inactivation dur-
ing BPA stimulation.
ICI does not prevent BPA-induced JKT-1 
proliferation. We recently reported that JKT-1 
cells express ER-β but not ER-α (Roger et al. 
2005). By immunofluorescence, subcellular 
fractionation, and Western blot, we found 
that the ER-β receptor had an apparent intra-
cyto  plasmic localization without any evident 
membrane location (Bouskine et al. 2008). 
To determine whether ER-β was involved in 
the estrogenic or xeno  estrogenic activation of 
JKT-1 cell proliferation, we tested the effect 
of ICI, a pure ER antagonist. ICI completely 
counter  acted the suppressive effects of E2 and 
DES on JKT-1 cell proliferation (Figure 5), 
supporting an ER-β–dependent mechanism. 
However, ICI did not prevent the promoting 
effect of BPA or of E2-BSA, supporting our 
hypothesis that the rapid effect induced by 
these two ligands was likely not dependent on 
a classical ER (Figure 5).
BPA stimulates proliferation in JKT-1 
cells through a G-protein–coupled receptor 
(GPCR). GPCRs have been proposed to 
be involved in triggering membrane action 
of steroids (Thomas et al. 2006), includ-
ing estrogens (Filardo et al. 2002; Kelly and 
Wagner 1999). PKA activation is usually a 
Gαs protein-dependent mecha  nism, so we 
tested the effect of NF449, a Gαs inhibi-
tor (Figure 6). NF449 blocked the pro-
moting effect of BPA, illustrating the Gαs 
dependence of the PKA activation and the 
G-protein–coupled nature of the receptor 
involved in BPA stimulation. We have pre-
viously shown that E2-BSA, which triggers 
an effect quite similar to that of BPA, also 
induces a Gαi-dependent activation of the 
mitogen-activated protein kinase (MAPK)/
ERK1/2 pathway (Bouskine et al. 2008). 
For this reason, we also studied the effect of 
PTX, an inhibitor of Gαi/Gαq protein, dur-
ing BPA-induced JKT-1 proliferation. This 
Figure 3. Promotion of cell proliferation in JKT-1 
cells through activation of the PKA pathway. (A) 
Exposure to BPA or E2-BSA (both at 10–9 M) with 
or without inhibition of PKA by H89 (5 × 10–6 M) for 
90 min; values shown are the percent change in 
cell number (mean ± SE) compared with control 
(steroid-free medium with DMSO for BPA or medium 
containing ethanol for E2-BSA). (B) Western blot 
analysis of CREB phosphorylation (pCREB; top) and 
actin expression in each sample (bottom) during 
exposure to 10–9 M BPA. Forskolin (25 µM) was used 
as a positive control for CREB activation. (C) Bands 
from three experiments were quantified by den-
sitometry, and results were normalized to actin 
expression in each sample, plotted with SE, and 
compared with control (time 0). 
*p < 0.05.
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Figure 4. Activation of Rb phosphorylation during 
BPA activation. (A) Western blot analysis of Rb 
phosphorylation (pRb) during activation with BPA 
(10–9 M) for the indicated time points. (B) Bands 
from three experiments quantified by densitometry 
and compared with control (steroid-free medium 
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*p < 0.05. 
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Figure 5. Effect of 90-min pretreatment with ICI on 
cell proliferation in JKT-1 cells treated for 24 hr 
with E2, DES, E2-BSA, BPA (all at 10–9 M). Values 
shown are percent change in cell number com-
pared with control (steroid-free medium containing 
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toxin prevented the BPA-induced increase of 
cell proliferation (Figure 7).
PKG pathway but not MAPK pathway 
is activated by BPA in JKT-1 cells. BPA 
promotion of JKT-1 cells did not seem to 
involve ERK1/2 activation because PD, an 
inhibitor of MAPK kinase, did not prevent 
BPA-enhanced proliferation (Figure 8). We 
therefore tested the PKG pathway, which 
is known to be Gαi/Gαq dependent and is 
involved in BPA activation of calcium influx 
in pancreatic islet α cells (Alonso-Magdalena 
et al. 2005). KT5823, an inhibitor of PKG 
activation, prevented BPA-induced JKT-1 
proliferation (Figure 6).
These results strongly support the partici-
pation of a membrane GPCR involving both 
the Gαs and Gαi subunits. Figure 9 summa-
rizes the signaling pathways activated during 
BPA induced JKT-1 proliferation.
Discussion
In this article we demonstrate for the first 
time that very low doses of BPA (picomolar or 
nanomolar) stimulate human seminoma cell 
proliferation by allowing a rapid, non  genomic, 
membrane-initiated activation of PKA and 
PKG signaling pathways associated with phos-
phorylation of the transcription factor CREB 
and the cell cycle regulator Rb. This promot-
ing effect, similar to the one observed with 
E2-BSA but not with E2 alone (Bouskine et al. 
2008), was triggered independently of classical 
ERs through a membrane receptor belonging 
to the GPCR family. The low concentrations 
of BPA able to produce such an effect give this 
observation environmental relevance and sup-
port the hypothesis of a possible contribution 
of xenoestrogenic fetal exposure to testicular 
germ cell carcinogenesis.
Estrogens classically mediate their action 
after binding to nuclear receptors that act as 
transcription factors to modulate the activ-
ity of target genes by interacting with several 
DNA response elements. In addition to their 
ability to mediate gene transcription, estrogens 
also elicit rapid nontranscriptional effects by 
membrane-mediated signaling pathways lead-
ing to calcium influx (Chaban et al. 2004), 
cAMP (Abraham et al. 2003) or nitric oxide 
production, phospholipase C activation, or 
inositol phosphate generation (Le Mellay et al. 
1997). The MAPK/ERK1/2 pathway can also 
be rapidly activated by estrogens in various cell 
types, such as endothelial (Chen et al. 2004), 
adipocyte (Dos Santos et al. 2002), neuroblas-
toma (Watters et al. 1997), or breast cancer 
cell lines (Migliaccio et al. 1996). Membrane 
activation of these rapid signaling cascades will 
then modulate gene transcription (Vasudevan 
and Pfaff 2007). We have recently reported 
that human seminoma cells express both clas-
sical ER-β (Roger et al. 2005) and a mem-
brane non  classical estrogen GPCR (Bouskine 
et al. 2008). E2 has a high affinity for ER-β 
and triggers a suppressive effect in JKT-1 cells, 
whereas E2 coupled to BSA, which prevents 
membrane crossing, binds to an ncmER and 
promotes cell proliferation by activating rapid 
cell signaling, including PKA and MAPK path-
ways (Bouskine et al. 2008). BPA has a low 
affinity for ER-β, as described in several mod-
els, with a 1,000-fold weaker affinity than E2, 
and activates pancreatic islet, hypophysial, or 
endometrial cells through an ncmER (Alonso-
Magdalena et al. 2005; Bulayeva and Watson 
2004; Nadal et al. 2000; Noguchi et al. 2002). 
In JKT-1 cells, the differential affinity toward 
both receptors may explain the dose–response 
curve observed. At high micromolar concentra-
tions, BPA may trigger a suppressive effect via 
ER-β as does E2, which neutralizes the nonge-
nomic effect. At low concentration (10–9 M), 
this genomic effect is absent, allowing the non-
genomic effect to be displayed because of the 
high affinity of BPA for the ncmER. When 
mixed together at this low concentration, BPA 
and E2 are mutually antagonistic, whereas 
DES, also a potent ligand for nuclear ER, at 
this low concentration only moderately coun-
teracts the non  genomic BPA effect, possibly 
for conformational reason. Our model illus-
trates the paradoxical inversed U-shaped curve, 
explaining effects at very low doses (Brucker-
Davis et al. 2001), that has been described for 
BPA in several models (Maffini et al. 2006; 
vom Saal and Hughes 2005; Welshons et al. 
2006), which could be produced by two differ-
ent ERs and two different, genomic and non-
genomic, mechanisms.
We propose that the promoting effect 
occurs through nongenomic transduced activa-
tion of the PKA/CREB and the PKG pathways, 
as illustrated by the very rapid phosphorylation 
of CREB and the inhibition of both CREB 
phosphorylation and proliferation obtained 
with the PKA antagonist H89 and the PKG 
inhibitor NF449. Phosphorylated CREB will 
regulate cell-cycle–controlling genes as dem-
onstrated by Rb phosphorylation. Estrogenic 
activation of the PKA/CREB pathway through 
an ncmER has already been described in sev-
eral models (Belcher et al. 2005; Filardo et al. 
2002; Quesada et al. 2002). Concerning ERK 
activation, Wozniak et al. (2005) assessed the 
rapid changes in intra  cellular calcium levels 
induced by xeno  estrogens in a pituitary tumor 
cell line and found that multiple membrane-
initiated signaling pathways were activated. 
The differential patterns presented seemed to 
depend on the structure of the xeno  estrogens 
and the conformation obtained with the mem-
brane ER (Wozniak et al. 2005). In particular, 
BPA was one of the EDCs tested that did not 
Figure 7. Effect of 90-min pretreatment with PTX 
(100 ng/mL) on GPCR-mediated activation of JKT-1 
cell proliferation induced by 24-hr exposure to 
BPA (10–9 M). Values shown are percent change 
in cell number compared with control (steroid-free 
medium with DMSO) given as the mean ± SE of 
three independent experiments.
*p < 0.05. 
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Figure 8. BPA promotion of JKT-1 cell proliferation 
is not ERK1/2 dependent. After 90-min pretreatment 
with PD (10–6 M), cells were exposed to E2-BSA or 
BPA (10–9 M) for 24 hr. Values shown are percent 
change in cell number compared with control (ste-
roid-free medium containing DMSO for BPA and 
medium containing ethanol for E2-BSA) given as 
the mean ± SE of three independent experiments. 
*p < 0.05. 
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Figure 9. Proposed model showing the process by 
which BPA stimulates JKT-1 cell proliferation by 
activating PKA and PKG pathways via a nonclassi-
cal GPCR. Solid lines represent demonstrated steps, 
and dotted lines represent possible pathways yet to 
be demonstrated. AC, adenylate cyclase.Nongenomic promoting effect of bisphenol A on seminoma cells
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induce ERK activation (Wozniak et al. 2005), 
as in our seminoma cell model. In another 
model of pancreatic islet α cells, Alonso-
Magdalena et al. (2005) showed that estrogens 
induce a rapid calcium influx through several 
pathways, including PKG. We therefore tested 
the PKG pathway, which involves for its acti-
vation a Gαq subunit, and found its contribu-
tion in BPA-induced JKT-1 proliferation as 
well, likely through a rapid intra  cyto  plasmic 
calcium increase. Then, we showed that the 
BPA proliferation-promoting effect on semi-
noma cells in fact needed the two subunits 
Gαs and Gαi, which acted not in an opposite 
but in a complementary fashion, as already 
described in other models (Daaka et al. 1997) 
and supported in JKT-1 cells by the use of 
specific inhibitors. Indeed, activation of both 
the PKA and PKG pathways seemed to be nec-
essary for the BPA-induced promoting effect, 
as we have previously shown for E2-BSA with 
the two PKA and ERK pathways (Bouskine 
et al. 2008). BPA, when mixed with E2-BSA, 
showed the same proliferative effect as each 
compound alone, without any synergistic or 
antagonistic effect. Despite the mild difference 
in the activated protein kinases, it is likely that 
this promoting effect induced by E2-BSA and 
BPA is mediated via the same GPCR mem-
brane receptor, an ncmER. 
Increasing evidence from different tissues 
and cell types has suggested that there are mul-
tiple mechanisms through which estradiol can 
stimulate rapid intracellular signaling (Kelly 
and Levin 2001; Manavathi and Kumar 2006). 
However, one of the main questions remains 
the nature of the coupled receptors. Different 
studies of nonclassical estrogen signaling in 
a variety of target cells, such as endothelial, 
neuronal, and pituitary cells (Kim et al. 1999; 
Li et al. 2003), have strongly suggested that 
nuclear classical ER or ER-like proteins are 
candidates (Pedram et al. 2006) for the mem-
brane ERs. In our model, however, this mem-
brane receptor is unlikely to be a classical ER 
because ICI failed to inhibit cell proliferation; 
JKT-1 cell membranes do not express ERβ as 
we previously reported (Bouskine et al. 2008); 
and E2 and DES, a potent synthetic estrogen 
that binds to ER, do trigger not a promoting 
but a suppressive effect. Filardo et al. (2002) 
showed that estrogen-induced ERK activation 
may occur in human breast cancer cells that 
do not express either ER-α or ER-β. GPR30, 
an orphan GPCR, has been proposed as a 
non  classical estrogen receptor able to stimu-
late cancer cells (Albanito et al. 2007; Filardo 
2002; Revankar et al. 2005; Thomas et al. 
2005; Vivacqua et al. 2006). Thus, GPR30 is a 
candidate for our ncmER in JKT-1 seminoma 
cells, activated by E2-BSA or BPA and able to 
transduce the PKA and ERK or PKG signal-
ing pathways. Moreover, GPR30 has been 
identified recently in mouse spermatogonia 
and has also been involved in estrogenic germ 
cell proliferation control (Sirianni et al. 2008). 
Seminoma cells are considered to be issued 
from transformed gonocytes or undifferenti-
ated spermatogonia (Rajpert-De Meyts 2006). 
Thus, we propose that GPR30 could repre-
sent the ncmER in JKT-1 seminoma cells, 
able to activate PKA, ERK, or PKG pathways. 
Studies of its expression, precise localization, 
and involvement in triggering an estrogenic 
promoting effect in human seminoma cells 
and human fetal or adult germ cells are now 
under way in our laboratory.
It is now possible, as we recently pro-
posed (Bouskine et al. 2008), to more com-
prehensively describe actions of estrogens at 
low concentrations on human seminoma cells, 
involving two different and opposite effects: 
first, a predominant long-lasting, suppressive 
effect, antagonized by ICI, thus likely mediated 
by ER-β, which involves a classical nuclear 
genomic pathway controlling cell cycle gene 
expression (Roger et al. 2005); and second, a 
rapid, non  genomic promoting effect triggered 
by PKA and ERK activation, which involves 
not a classical ER (not antagonized by ICI or 
tamoxifen), but rather a PTX-responsive non-
classical membrane estrogen GPCR (Bouskine 
et al. 2008). The resulting impact on germ cells 
may depend on the relative expression of both 
receptors (ER-β and GPCR), the endogenous 
concentration of E2, and the respective binding 
affinity of the estrogenic compounds. In the 
presence of both receptors, as in JKT-1 semi-
noma cells, the suppressive effect of E2 may 
remain predominant because of a rapid dephos-
phorylation of ERK1/2 by an ER-β-dependent 
expression of protein phosphatase 2A, as 
described in neonatal rat cerebellar neurons 
(Belcher et al. 2005). In contrast, in JKT-1 
cells, BPA does not need the MAPK pathway, 
but rather the PKG pathway, which would 
have a more potent effect on the non  genomic 
pathway because BPA has a higher affinity for 
this receptor. Furthermore, human gono  cytes, 
which do not express the active ER-β1 isoform 
until the pre  natal period (Gaskell et al. 2003), 
may be exclusively sensitive to the membrane-
mediated promoting effect if they do express 
the ncmER as do mouse spermatogonia 
(Sirianni et al. 2008). Progressive expression of 
ER-β1 during the peri  natal period will prevent 
proliferation and enhance differentiation into 
spermatogonia. However, excessive fetal expo-
sition to xeno  estrogens with high affinity for 
the non  classical estrogen GPCR, as shown here 
for BPA, may promote abnormal proliferation 
of gonocytes through the non  genomic path-
way and thus contribute to malignant germ 
cell transformation, leading, as proposed by 
Skakkebaeck et al. (1998), to carcinoma in situ 
and then to testicular germ cell cancer, the 
most frequent cancer of the young men with 
an increasing incidence.
This GPCR-mediated nongenomic action 
therefore represents a new basis for evaluating 
xenoestrogens such as BPA that could interfere 
with the developmental programming of fetal 
germ cell proliferation and/or differentiation 
when it crosses the placenta. Testing of EDCs 
will require a cell model that expresses this recep-
tor alone and/or together with nuclear ERs.
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